We are live on ! Find out more
SLS icon

SELLAS Life Sciences
SLS

34 hedge funds and large institutions have $4.57M invested in SELLAS Life Sciences in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,396% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $84K

0% less ownership

Funds ownership: 0.02% → 0.01% (-0%)

9% less capital invested

Capital invested by funds: $5.02M → $4.57M (-$453K)

32% less funds holding

Funds holding: 50 → 34 (-16)

45% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 11

70% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 23

Holders
34
Holders Change
-16
Holders Change %
-32%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
11
Closed
23
Calls
$1.26M
Puts
$84K
Net Calls
+$1.17M
Net Calls Change
-$65K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$360K
2
VKH
Virtu KCG Holdings
New York
+$113K
3
SM
Sabby Management
Florida
+$104K
4
ECM
Element Capital Management
New York
+$93.1K
5
PP
Paloma Partners
Connecticut
+$70.5K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$318K
2
Millennium Management
Millennium Management
New York
-$114K
3
State Street
State Street
Massachusetts
-$84.4K
4
SG Americas Securities
SG Americas Securities
New York
-$77K
5
Deutsche Bank
Deutsche Bank
Germany
-$53.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
26
Guggenheim Capital
Illinois
$7K – – –
Citigroup
27
Citigroup
New York
$4K +$1.74K +2 +67%
ST
28
Spot Trading
Illinois
$3K – – –
WA
29
Winfield Associates
Ohio
$2K – – –
MAM
30
Meeder Asset Management
Ohio
$1K – – –
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$2 – – –
SG Americas Securities
32
SG Americas Securities
New York
– -$77K -84 Closed
Deutsche Bank
33
Deutsche Bank
Germany
– -$53.1K -61 Closed
AL
34
Airain Ltd
Guernsey
– -$53K -57 Closed
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
– -$39K -43 Closed
CS
36
Credit Suisse
Switzerland
– -$33K -37 Closed
TCIM
37
TIAA CREF Investment Management
New York
– -$19K -21 Closed
TA
38
Teachers Advisors
New York
– -$16K -18 Closed
UBS Group
39
UBS Group
Switzerland
– -$13.1K -15 Closed
JP Morgan Chase
40
JP Morgan Chase
New York
– -$13K -14 Closed
NCCM
41
Nine Chapters Capital Management
New Jersey
– -$13K -14 Closed
Mariner
42
Mariner
Kansas
– -$9K -10 Closed
Charles Schwab
43
Charles Schwab
California
– -$9K -9 Closed
TSS
44
Two Sigma Securities
New York
– -$8K -9 Closed
Barclays
45
Barclays
United Kingdom
– -$7K -8 Closed
Bank of America
46
Bank of America
North Carolina
– -$4.35K -5 Closed
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
– -$5K -5 Closed
PCM
48
Prelude Capital Management
New York
– -$4.35K -5 Closed
AIG
49
American International Group
New York
– -$3K -4 Closed
NFA
50
Nationwide Fund Advisors
Ohio
– -$4K -4 Closed
1
2
3

SLS Hedge Fund Activity: Q2 2017 in Review

34 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q2 2017, worth a combined $4.57M — down 9% from $5.02M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SLS and 7 opened new positions — a net loss of 16 holders — while 11 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, adding an estimated $360K. The largest seller was BlackRock, cutting an estimated $318K.

  • 34 institutional investors held SELLAS Life Sciences (SLS) as of Q2 2017, down from 50 in Q1 2017.
  • Funds reported $4.57M of SELLAS Life Sciences stock for Q2 2017, down 9% quarter-over-quarter.
  • 7 funds opened new SELLAS Life Sciences positions in Q2 2017 and 23 closed out, a net change of -16 holders.
  • The largest SELLAS Life Sciences buyer in Q2 2017 was Renaissance Technologies, an estimated $360K added.
  • The largest SELLAS Life Sciences seller in Q2 2017 was BlackRock, an estimated $318K sold.

Based on aggregated 13F filings for Q2 2017.